Five categorical variables (users vs non-users of (a) insulin formulations or insulin analogues, (b) insulin secretagogues, (c) metformin, (d) thiazolidinediones, and (e) other anti-diabetic medications) were used to examine the anti-diabetic medication usage pattern in MM patients with HxD and SID (Supplementary Table 2).
Future outcome studies should measure patterns of medication usage to investigate this further.
This RCT will investigate the effects of structured, progressive exercise on PTSD symptoms, functional ability, body composition, physical activity levels, sleep patterns and medication usage.
Secondary outcome measures will assess depression and anxiety, mobility and strength, body composition, physical activity levels, sleep patterns and medication usage.
The current RCT will investigate the effects of structured, progressive exercise on PTSD symptoms, depression and anxiety, mobility and strength, body composition, physical activity levels, sleep patterns and medication usage among people with a DSM-IV diagnosis of PTSD.
Patterns of medication usage have also been evaluated, and those used for major asthma attacks - such as nebulisers and oral steroids - appear to be valid markers for asthma severity [ 27].
This study will determine the effect of an individualised and progressive exercise intervention on PTSD symptoms, depression and anxiety, mobility and strength, body composition, physical activity levels, sleep patterns and medication usage among people with a DSM-IV diagnosis of PTSD.
This study investigated changes in usage patterns of medications in Australia following two examples - rofecoxib market withdrawal (2004) and warnings about jaw necrosis following bisphosphonates (2007).
The two cohorts were otherwise similar in demographic composition, medical comorbidities and medication usage at inclusion.
The aim of this study was to investigate changes in usage patterns of key medications in Australia following rofecoxib market withdrawal (COX-2 inhibitor usage 2000 2008) and after the widespread warnings about bisphosphonates (usage 2003 2012), and the resulting publicity (both scholarly publications and public media) about these adverse medication events.
